Model
Edge
Telomir Pharmaceuticals Inc.
0001971532
Filing Type
8-K
Filing Date
3/26/2026
Updated
3/27/26, 3:25 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Shareholder votes
EX-3.1
EX-3.1
EX-10.1
EX-10.1